Inactivation of AKT/NF-κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin

The high activation of protein kinase B (AKT)/nuclear factor-κB (NF-κB) signaling has often been associated with the induction of non-small cell lung cancer (NSCLC) cell survival and resistance to cisplatin, which is one of the most widely used chemotherapeutic drugs in the treatment of NSCLC. The i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dukaew, Nahathai, Chairatvit, Kongthawat, Pitchakarn, Pornsiri, Imsumran, Arisa, Karinchai, Jirarat, Tuntiwechapikul, Wirote, Wongnoppavich, Ariyaphong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448543/
https://www.ncbi.nlm.nih.gov/pubmed/32945500
http://dx.doi.org/10.3892/or.2020.7710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448543/
https://www.ncbi.nlm.nih.gov/pubmed/32945500
http://dx.doi.org/10.3892/or.2020.7710

Ejemplares similares